Sign in
Not yet taking people in United StatesNo phase

NeuroCuple to Mitigate Post-Wisdom Teeth Extraction Opioid Risks

Key facts

Who runs it
nCap Medical
Where
Pittsburgh, United StatesSee the site
Trial code
Status
Not yet recruiting
People taking part
120 people, planned
Started
30 Jun 2026
Expected to end
30 Sept 2027
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • NEUROCUPLE™ Patch
  • Sham Patch
Record updated
31 March 2026

Who can take part

Age
18 years to 50 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 22 criteriaShow less

Who can take part

  • Males and females of all races and ethnicity
  • >18 to 50 years
  • Healthy based on medical history
  • Scheduled for elective extraction of one or more partially or fully impacted mandibular third molars
  • Able to understand and sign the informed consent form
  • Willing and able to comply with all study procedures
  • Available for the duration of the study
  • Able to understand the directions for data gathering instruments

Who cannot take part

  • Other concomitant surgery being performed in addition to third molar extraction
  • Currently taking CYP3A4 inhibitors, azole-antifungal agents, protease inhibitors, or CNS depressants
  • Active alcoholism or illicit drug abuse (defined as daily use of illicit drugs)
  • History of gastrointestinal bleeding and/or peptic ulcer, renal disease (excluding kidney stones), hepatic disease, bleeding disorder, respiratory depression
  • History of respiratory depression with opioids or other anesthetic drugs that required postoperative ventilatory support or naloxone
  • Known allergy to ibuprofen, acetaminophen, oxycodone, hydrocodone, and/or anesthesia
  • History of substance or alcohol abuse
  • History of substance or alcohol abuse in a first-degree relative
  • Children (< 18 years of age)
  • T-score ≥ 60 in any of the three PROMIS measures (i.e., sleep, anxiety, and depression)
  • Active or untreated asthma
  • Consumes three or more alcoholic drinks per day
  • No more than one opioid prescription filled within the past 12 months (self-report and PDMP)
  • Pregnant or lactating women; Sex, race, and ethnicity will not be used as exclusion criteria

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 50 years old?

Where in United States

  • University of Pittsburgh School of Dental MedicinePittsburgh, United StatesContact: Dan Hawkins, DMD, FACSNot yet recruiting

About the trial

What the trial wants to find out

This is a randomized (1:1), placebo-controlled clinical trial that will examine the feasibility and effectiveness of a 2-day application of the NeuroCuple device for pain relief and reduction of opioid use following wisdom teeth extraction. The primary objectives are to determine whether the active NeuroCuple reduces postoperative pain and decreases opioid consumption compared to a sham (placebo) device. A total of 120 participants will be enrolled over a 1-year period and randomized to receive either the active device or an identical-appearing placebo device without the captor array layer.

The 2 groups in the trial

  • NEUROCUPLE™ GroupTreatment being tested

    This arm of subjects will receive the active NEUROCUPLE™ patch to wear for 2-days following their Wisdom Teeth Extraction procedure

    Treatment: NEUROCUPLE™ Patch

  • Sham GroupSham treatment, for comparison

    This arm of subjects will receive the placebo (non-active, sham) patch to wear for 2-days following their Wisdom Tooth Extraction procedure

    Treatment: Sham Patch

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Mitigating Opioid Use Disorder Risk With Enhanced Opioid Sparing Pain Relief for Wisdom Teeth Extractions With a Novel Nanotechnology
Criteria questions
Built from NCT07461506, who can take part
Record updated
31 March 2026